Cogentix Medical, Inc. (NASDAQ:CGNT) produced a 127.01% rally since recording the worst price of $1.37. Thanks to the latest 8.74% increase, it now trades at $3.11. Throughout the trading on Oct. 6, 2017, the share price floated between $2.91 and $3.24. This company shares are -3.54% up from its target price of $3 and the current market capitalization stands at $180.19M. The recent change has given its price a 29.93% lead over SMA 50 and -4.6% deficit over its 52-week high. The stock witnessed 27.72% gains, 90.8% gains and 90.8% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found CGNT’s volatility during a week at 8.27% and during a month it has been found around 8.74%.Cogentix Medical, Inc. (CGNT) Top Holders
Institutional investors currently hold around $25 million or 39.8% in CGNT stock. Look at its top three institutional owners. Nantahala Capital Management, Llc owns $11.3 million in Cogentix Medical, Inc., which represents roughly 6.27% of the company’s market cap and approximately 45.21% of the institutional ownership. Similar statistics are true for the second largest owner, Broadfin Capital, Llc, which owns 1,094,544 shares of the stock are valued at $3.4 million. The third largest holder is Perkins Capital Management Inc, which currently holds $2.01 million worth of this stock and that ownership represents nearly 1.11% of its market capitalization.
At the end of 06/30/2017 reporting period, 12 institutional holders increased their position in Cogentix Medical, Inc. (NASDAQ:CGNT) by some 739,080 shares, 22 decreased positions by 757,654 and 12 held positions by 6,591,506. That puts total institutional holdings at 8,088,240 shares, according to SEC filings. The stock grabbed 3 new institutional investments totaling 17,362 shares while 10 institutional investors sold out their entire positions totaling 163,209 shares.Cogentix Medical, Inc. (NASDAQ:CGNT) Insider Trades
Multiple company employees have indulged in significant insider trading. Cogentix Medical, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Samet Kenneth A has acquired 25,000 shares of Cogentix Medical, Inc. (CGNT) in trading session dated Nov. 18, 2016. These shares are worth $61,750 and were traded at $2.47 each. The SEC filing shows that Pell Lewis C performed a purchase of 13,291 shares. The Director added these shares by way of transaction on Jun. 10, 2016. The company’s shares were assimilated at $0.95 per share worth to an investment of some $12,626 on account of Pell Lewis C.
Director, Pell Lewis C, purchased 894 common shares of Cogentix Medical, Inc. (CGNT) in the open market. In a transaction dated Jun. 01, 2016, the shares were bought at an average price of $0.75, giving away a sum of $671. After this purchase, 2,350,009 common shares of CGNT are directly owned by the insider, with total stake valued at $7,308,528.
In the transaction dated May. 31, 2016, the great number of shares acquired came courtesy the Director; Pell Lewis C added a total of 500,000 shares at an average price of $0.79, amounting to approximately $395,000. The insider now directly owns 2,349,115 shares worth $7,305,748.Cogentix Medical, Inc. (CGNT) Analyst Guide
Not many analysts have released their opinion on Cogentix Medical, Inc. (NASDAQ:CGNT), with 1 analysts believing it is a strong buy. Whereas 0 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1 average brokerage recommendation.